Background: High-risk neuroblastoma is the most frequent extra-cranial solid tumor in childhood,
and is faced with poor prognosis despite intensive therapy. Allogeneic stem cell transplantation
in combination with adoptive recipient leukocyte infusion (RLI) has been proposed
as a potentially promising new strategy, and has already been shown to be effective
in murine neuroblastoma models.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of CancerAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
P07.04
Identification
Copyright
© 2018 Published by Elsevier Inc.
